BOCA RATON, Fla., Nov. 7, 2006 (PRIMEZONE) -- StockMarketNewsAlert.com issues New Trade Alert for Deep Blue, Inc. (Pink Sheets:DPBL). According to M. D'Alonzo at First Equity Group Inc., recent news flow from the company has been very positive, "The company announced Specific Services Group, a consultant under contract with Deep Blue, Inc., has committed to provide the interim funding necessary for Deep Blue to enter into a contract with a leading hospital in the Midwest to conduct its FDA approved Single-Site Human Trials for HIV/AIDS. Management now believes this transaction should be complete in the next two to three weeks at which time the hospital will be revealed and patient screening will begin. The trials will start immediately after the patient screening has been completed. The time frame from initiation of the trials to their completion is approximately four months. While the trials progress, Deep Blue has multiple tracks to investigate. Several U.S. medical institutes are being considered to launch Phase II Multi-Site Trials. Review boards have been contacted and due to our FDA approval, the process has been streamlined dramatically.
Deep Blue, Inc. (www.deepblueinc.com) is bringing to market an innovative patent-pending treatment, (Application Number 11/208,402), for HIV/AIDS and other viral infectious diseases.
Deep Blue, Inc. also reveals North American Market Potential to be approximately 1 million people in North America living with HIV at present; with a 15% market penetration our treatment protocols would provide gross receipts of $3.75 billion per annum. Additionally, in this market there are 44,000 new cases of HIV each year. Even if only 15% of newly diagnosed cases participated, with fees of $25,000 per patient, the additional revenue would be approximately $165,000,000 per year.
The number of patients treatable per day depends on the size and availability of the hyperbaric chamber. For our baseline analysis, we will use a state of the art 24-patient multi-place class "A" chamber, with 16 hours each day for scheduled use. Under these parameters, 240 patients per day could be treated per facility and Deep Blue could feasibly treat 140 such groups or approximately 3,300 patients at each facility in one year. This would equate to gross receipts per facility of over $80,000,000 per year.
Deep Blue, Inc. (www.deepblueinc.com) is bringing to market an innovative patent-pending treatment, (Application Number 11/208,402), for HIV/AIDS and other viral infectious diseases.
Cautionary Statement:
This news release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Although Deep Blue, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included herein, the inclusion should not be regarded as a representation by Deep Blue, Inc., or any other person that the objectives and plans of Deep Blue, Inc. will be achieved.
About StockMarketNewsAlert.com
StockMarketNewsAlert.com was developed solely for experienced, risk-tolerant investors. Subscribers to StockMarketNewsAlert.com receive daily market commentary reports for select companies trading on various markets. Sophisticated investors are also able to receive for free, select, rare research reports and investor kits on up and coming emerging companies while they are still not widely known.
StockMarketNewsAlert.com's (SMNA) primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small- and micro-cap companies. StockMarketNewsAlert.com is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. SMNA's goal is to feature equity investments in micro- or small-capitalization companies that have the potential for long-term appreciation. SMNA provides investors with a complete suite of online interactive financial data and tools that includes quotes, charts, company profiles, news, market commentary and SEC filings, just to name a few. Stockmarketnewsalert.com offers a free financial newsletter. To subscribe or get more information, visit our home page located at www.stockmarketnewsalert.com.
Let Stock Market News Alert help advertise for your company using our effective awareness campaigns. If you're interested in telling your story, we can help. Contact us at info@stockmarketnewsalert.com. SMNA's e-mail alert service is free to those investors who sign up on the SMNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. To subscribe to this free service, visit the Stock Market News Alert home page at http://www.stockmarketnewsalert.com and select the "sign up" button.
Information contained herein is the opinion of stockmarketnewsalert.com and is intended to be used strictly for informational purposes. You should be aware that SMNA attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, SMNA does, at times, rely on the accuracy of information supplied to it by the companies, which are the subject of SMNA's analyses and/or parties related to those companies. SMNA also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
SMNA, because it relies on information supplied by various third parties, disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a SMNA analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an SMNA opinion, recommendation or analysis.
Information regarding companies, which SMNA has an opinion upon, is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.
All material herein is information supplied by the company or other sources believed to be reliable. The information contained herein is not guaranteed by First Equity Group, Inc. to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this profile have approved the statements made in this profile. This profile contains forward-looking statements that involve risks and uncertainties. Statements in this press release about the company's future expectations other than historical facts, are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, section 21E of the Securities Act of 1934, as that term is defined in the Private Securities Litigation Reform Act of 1995. It is important to note that actual results and ultimate corporate actions could differ materially from those in such forward-looking statements. Such "forward-looking statements" are subject to risks and uncertainties set forth from time to time in the company's SEC reports that could cause results to differ materially from those expressed or implied include, but are not limited to, the results of future tests and the availability of funding for additional research and development. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. First Equity Group is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.stockmarketnewsalert.com. First Equity Group has received compensation of four hundred thousand free trading shares from Griffen Trading Company a non-affiliated third party. First Equity Group's affiliates, officers, directors, and employees may also have bought or may buy the shares discussed in this profile and may profit in the event those shares rise in value. First Equity Group does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.